AstraZeneca continues to be a topic of discussion… The Covid-19 vaccine is said to have caused three more cases of thrombosis that occurred between March 19 and 25, 2021 in France – according to the French Medicines Agency or Agence du Médicament (ANSM) in France. Two people reportedly died.
In all, since the vaccination campaign started, the ANSM has found in the country “twelve cases, including four deaths” related to these rare thromboses. These cases involve “thromboses of large veins atypical because of their location (mostly in the brain, but also in the stomach), likely associated with thrombopenia (blood platelet failure – Editor’s Note) or blood coagulation failure”, the ANSM added on April 2.
These cases of thromboses occurred in an average nine-day period past AstraZeneca vaccine inoculation, mainly in women without previous common history previously identified.
The ANSM also issued recommendations. People given one dose of the vaccine must immediately make an appointment with a doctor in case of persisting symptoms beyond 3 days. Among symptoms to control, there are: “shortness of breath, thoracic pain, leg swelling, abdominal pain, severe headaches, blurry eyesight, or hematomas far from the injection site”.
Covid and AstraZeneca: what is a thrombosis?
As the AstraZeneca Covid vaccine has been sparking questions after suspicious cases of thrombosis ten days following injection, the editorial board has decided to focus on what thromboses are medically speaking. Risks, symptoms, treatments… Here is more on the matter!
Even though the health agency once again confirms “the very rare occurrence of this thrombotic risk” in people vaccinated with AstraZeneca, they intended to remind the positive benefit-risk ratio of vaccinating with this solution.